What is the address of DSDM PHARMA?

The registered office of DSDM PHARMA is located at Beekstraat 145, 9031 Gent.

Is DSDM PHARMA still active?

Yes. According to the CBE (31 October 2026) DSDM PHARMA is active, legal situation “Normale toestand”, started on 8 January 2008.

Is DSDM PHARMA registered on Peppol?

Yes, DSDM PHARMA is registered on the Peppol network with ID 0208:0894719585.

What is the enterprise number of DSDM PHARMA?

The enterprise number of DSDM PHARMA is BE0894719585.

When was DSDM PHARMA founded?

DSDM PHARMA was founded on 8 January 2008.

Who are the directors of DSDM PHARMA?

According to the 2025 annual accounts, the directors of DSDM PHARMA are: Stefanie De Sutter, Michel D'hont.

Is DSDM PHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 January 2008; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DSDM PHARMA make in 2025?

DSDM PHARMA posted a profit after taxes of € 211,084 in financial year 2025.

What is the revenue of DSDM PHARMA?

As a small company, DSDM PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 374,448.

How many employees does DSDM PHARMA have?

According to the 2025 annual accounts, DSDM PHARMA has 0 full-time equivalents (FTE).

DSDM PHARMA (Private Limited) - Gent - BE0894719585

Q: What does DSDM PHARMA do?

DSDM PHARMA is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 8 January 2008, 1 establishment.

Dossier DSDM PHARMA, printed on 31 October 2026 from databakkes.be/en/0894719585/dsdm-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DSDM PHARMA from Gent, company number BE0894719585, closed financial year 2025 with a result of € 211,084 after tax. For that financial year DSDM PHARMA recorded a gross margin of € 374,448 and equity of € 635,891. Compared with financial year 2024, the result moved from € 30,886 to € 211,084. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Growing

€ 635,891

▲ 50% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 211,084

▲ € 180,198 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 30,149

▼ 31% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 608,891.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 243,295

▼ 73% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 821,227

▼ 12% vs 2024

€ 121,242 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 4,460

▼ 35% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 76,752

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 96,608 Gross margin 2022: € 96,608 First fiscal year in the series	€ 118,522 Gross margin 2023: € 118,522 ▲ 23% vs 2022 (€ 96,608) Favourable step	€ 176,742 Gross margin 2024: € 176,742 ▲ 49% vs 2023 (€ 118,522) Favourable step	€ 374,448 Gross margin 2025: € 374,448 ▲ 112% vs 2024 (€ 176,742) Favourable step	▲ 112%
Profit after taxes	€ 37,318 Profit after taxes 2022: € 37,318 First fiscal year in the series	€ 43,790 Profit after taxes 2023: € 43,790 ▲ 17% vs 2022 (€ 37,318) Favourable step	€ 30,886 Profit after taxes 2024: € 30,886 ▼ 29% vs 2023 (€ 43,790) Unfavourable step	€ 211,084 Profit after taxes 2025: € 211,084 ▲ € 180,198 vs 2024 (€ 30,886) Favourable step	▲ € 180,198
Equity	€ 532,522 Equity 2022: € 532,522 First fiscal year in the series	€ 393,921 Equity 2023: € 393,921 ▼ 26% vs 2022 (€ 532,522) Unfavourable step	€ 424,806 Equity 2024: € 424,806 ▲ 8% vs 2023 (€ 393,921) Favourable step	€ 635,891 Equity 2025: € 635,891 ▲ 50% vs 2024 (€ 424,806) Favourable step	▲ 50%
Total debts	€ 480,326 Total debts 2022: € 480,326 First fiscal year in the series	€ 724,039 Total debts 2023: € 724,039 ▲ 51% vs 2022 (€ 480,326) Unfavourable step	€ 1,607,555 Total debts 2024: € 1,607,555 ▲ 122% vs 2023 (€ 724,039) Unfavourable step	€ 1,007,136 Total debts 2025: € 1,007,136 ▼ 37% vs 2024 (€ 1,607,555) Favourable step	▼ 37%
Cash	€ 31,791 Cash 2022: € 31,791 First fiscal year in the series	€ 18,268 Cash 2023: € 18,268 ▼ 43% vs 2022 (€ 31,791) Unfavourable step	€ 43,664 Cash 2024: € 43,664 ▲ 139% vs 2023 (€ 18,268) Favourable step	€ 30,149 Cash 2025: € 30,149 ▼ 31% vs 2024 (€ 43,664) Unfavourable step	▼ 31%
Land & buildings	€ 198,868 Land & buildings 2022: € 198,868 First fiscal year in the series	€ 205,672 Land & buildings 2023: € 205,672 ▲ 3% vs 2022 (€ 198,868) Unchanged	€ 299,062 Land & buildings 2024: € 299,062 ▲ 45% vs 2023 (€ 205,672) Unchanged	€ 242,684 Land & buildings 2025: € 242,684 ▼ 19% vs 2024 (€ 299,062) Unchanged	▼ 19%
Retained profit	€ 505,522 Retained profit 2022: € 505,522 First fiscal year in the series	€ 366,921 Retained profit 2023: € 366,921 ▼ 27% vs 2022 (€ 505,522) Unfavourable step	€ 397,806 Retained profit 2024: € 397,806 ▲ 8% vs 2023 (€ 366,921) Favourable step	€ 608,891 Retained profit 2025: € 608,891 ▲ 53% vs 2024 (€ 397,806) Favourable step	▲ 53%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 182,391 Dividend 2023: € 182,391 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 182,391) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 162,633 Bank debt 2022: € 162,633 First fiscal year in the series	€ 229,588 Bank debt 2023: € 229,588 ▲ 41% vs 2022 (€ 162,633) Unfavourable step	€ 931,774 Bank debt 2024: € 931,774 ▲ € 702,186 vs 2023 (€ 229,588) Unfavourable step	€ 821,227 Bank debt 2025: € 821,227 ▼ 12% vs 2024 (€ 931,774) Favourable step	▼ 12%
Balance sheet total	€ 1,012,849 Balance sheet total 2022: € 1,012,849 First fiscal year in the series	€ 1,117,960 Balance sheet total 2023: € 1,117,960 ▲ 10% vs 2022 (€ 1,012,849) Unchanged	€ 2,032,362 Balance sheet total 2024: € 2,032,362 ▲ 82% vs 2023 (€ 1,117,960) Unchanged	€ 1,643,027 Balance sheet total 2025: € 1,643,027 ▼ 19% vs 2024 (€ 2,032,362) Unchanged	▼ 19%

Key figures of DSDM PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DSDM PHARMA?

What happened at DSDM PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2026 New annual accounts for financial year 2025: profit of € 211,084 (▲ € 180,198 vs 2024). filed late Source: NBB ↗
Jan 8, 2008 New establishment in Gent. KBO
Jan 8, 2008 Start of the company according to the CBE. KBO
2008 Stefanie De Sutter became a director. NBB
2008 Michel D'hont became a director. NBB

In short

From € 37,318 profit in 2022 to € 211,084 profit in 2025.

Paid € 119,082 in corporate taxes since 2022.

Best year ever: 2025, with € 211,084 profit.

Paid out € 182,391 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Stefanie De Sutter Michel D'hont

APOTHEEK VLAEMINCK

DSDM PHARMA

Behind DSDM PHARMA are Stefanie De Sutter and Michel D'hont. The same people are also behind APOTHEEK VLAEMINCK.

Directors

According to the 2025 annual accounts

Stefanie De Sutter

Director

Also active at: APOTHEEK VLAEMINCK

since 2008

Michel D'hont

Director

Also active at: APOTHEEK VLAEMINCK

since 2008

Establishments

Establishment units

Physical locations of this company

Registered office

Beekstraat 145

9031 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

APOTHEEK VLAEMINCK same network

€ 263,192 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0894.719.585

VAT number

BE 0894.719.585

Registered office

Beekstraat 145, 9031 Gent

Names & denominations

DSDM PHARMA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

8 January 2008

Peppol

Active · Active since 23 Nov 2025

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Activiteiten van holdings

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

DSDM PHARMA

Financials

What happened to DSDM PHARMA?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions